FTC 16 CFR Part 255 - Testimonial and Results Disclaimer
Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
Australias Ken Rosewall is the oldest open era mens winner at 37 years and 62 days old, while Novak Djokovic was four months from turning 39 when he contested this years Australian Open final
However, according to the release on their site this is not what HIMS is doing at all
Theyre often prescribed for type 2 diabetes and weight loss
How it compares: Calibrate includes intensive one-on-one coaching and a structured year-long lifestyle program, but costs significantly more each month